ADA-friendly PDF: Consensus Statement Regarding Use of Elacestrant in Patients with Advanced Estrogen Receptor-Positive Breast Cancer

Elacestrant for Advanced Estrogen Receptor-Positive Breast Cancer

The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings on February 24 and May 5, 2023 to discuss recommendations for the use of elacestrant in patients with advanced estrogen receptor-positive breast cancer.